We are monitoring the impact of COVID-19 on MEA Therapeutic Vaccines Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 62
Share on
Share on

Middle-East and Africa Therapeutic Vaccines Market Research Report – Segmented By Disease Type and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 62
Pages: 136

MEA Therapeutic Vaccines Market Size (2020 to 2025)

The size of the Therapeutic Vaccines Market in MEA was calculated at USD 230.38 Million in 2020. It is forecasted to grow USD 1100 Million by 2025, growing at a CAGR of 36.71% from 2020 to 2025.

In the pipeline, several approaches are being developed to boost the immune response to various infectious and cancerous cells. There are presently close to 120 new vaccines in the pipeline of various multinational companies across the globe set to hit the market in the next few years.

HIV/AIDS is a major public health concern and COD in many parts of Africa. Although the continent is home to about 15.2 percent of the world's population, Sub-Saharan Africa alone accounted for an estimated 69 percent of all people living with HIV and 70 percent of all AIDS deaths in 2011. Recently, Aids treatment has shown promising results in a clinical trial in South Africa. The therapeutic vaccine makes antiviral drugs more effective by boosting the immune system of people living with the Aids virus, HIV. This probably marks the significant growth of therapeutic vaccines in the African sub-continent given the serious AIDS infected population. Combining this with Middle East economies' spending ability coupled with their recently booming markets, makes this region a lucrative one for the market players.

An increase in funding’s from the government for vaccine development, a rise in investments by the major market players, rising prevalence of the disease, technological advancements, initiatives by NGOs are some of the factors that are propelling the market growth. However, massive capital expenditures and stringent regulatory policies, and high costs associated with treatment are few factors inhibiting the market's growth.

This research report on the Middle-East & Africa Therapeutic Vaccines Market segmented and sub-segmented into the following categories:

By Disease Type: 

  • Autoimmune Disease
  • Cancer
  • Neurological Disease
  • Infectious Disease

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Some of the prominent companies leading the Middle-East & Africa Therapeutic Vaccines Market profiled in the report are GlaxoSmithKline, plc, Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Analysis Design                         

                2.3 Research Phases                      

                                2.3.1 Secondary Research            

                                2.3.2 Primary Research 

                                2.3.3 Econometric Modelling     

                                2.3.4 Expert Validation  

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Disease Type                       

                                5.1.1 Autoimmune Disease Vaccines      

                                5.1.2 Cancer Vaccines   

                                                5.1.2.1 Multikine

                                                5.1.2.2 PR1 Peptide

                                                5.1.2.3 TroVax

                                                5.1.2.4 CYT004-MelQbG10

                                5.1.3 Neurological Disease Vaccines        

                                                5.1.3.1 ACC- 001

                                                5.1.3.2 CAD 106

                                                5.1.3.3 Parkinson's Disease Vaccine

                                                5.1.3.4 Alzheimer's Disease

                                5.1.4 Infectious Disease Vaccines             

                                                5.1.4.1 Hepatitis C

                                                5.1.4.2 HIV/AIDS

                                                5.1.4.3 Other Infectious Disease

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 Middle East                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 GlaxoSMithKline plc.                              

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Merck and Company                              

                8.3 Bavarian Nordic                        

                8.4 CSL Limited                 

                8.5 Emergent Biosolutions Inc.                  

                8.6 Novartis AG                

                8.7 Johnson and Johnson                             

                8.8 MedImmune LLC                     

                8.9 Pfizer Inc.                    

                8.10 Sanofi Pasteur                        

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and identify the regions that are still untapped.
  • The segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies, and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions to provide both individuals and organizations a strong financial foothold in the market, investment opportunities Expertly devised analyst overview along with
  1. Middle East & Africa Therapeutic Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  2. Middle East & Africa Therapeutic Vaccines Market, By Disease Type, From 2020 to 2025 (USD Million)
  3. Middle East & Africa Autoimmune Disease Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  4. Middle East & Africa Cancer Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  5. Middle East & Africa Neurological Disease Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  6. Middle East & Africa Infectious Disease Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  7. Middle East & Africa Cancer Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  8. Middle East & Africa Multikine Market, By Region, From 2020 to 2025 (USD Million)
  9. Middle East & Africa PR1 Peptide Market, By Region, From 2020 to 2025 (USD Million)
  10. Middle East & Africa TroVax Market, By Region, From 2020 to 2025 (USD Million)
  11. Middle East & Africa CYT004-MelQbG10 Market, By Region, From 2020 to 2025 (USD Million)
  12. Middle East & Africa Neurological Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  13. Middle East & Africa ACC- 001 Market, By Region, From 2020 to 2025 (USD Million)
  14. Middle East & Africa CAD 106 Market, By Region, From 2020 to 2025 (USD Million)
  15. Middle East & Africa Parkinson's Vaccine Market, By Region, From 2020 to 2025 (USD Million)
  16. Middle East & Africa Alzheimer's Vaccine Market, By Region, From 2020 to 2025 (USD Million)
  17. Middle East & Africa Infectious Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  18. Middle East & Africa Hepatitis C Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  19. Middle East & Africa HIV/AIDS Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  20. Middle East & Africa Other Infectious Disease Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  21. Middle East Therapeutic Vaccines Market, By Disease Type, From 2020 to 2025 (USD Million)
  22. Africa Therapeutic Vaccines Market, By Disease Type, From 2020 to 2025 (USD Million)
  23. Middle East Cancer Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  24. Africa Cancer Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  25. Middle East Neurological Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  26. Africa Neurological Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  27. Middle East Infectious Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  28. Africa Infectious Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample